Keeping your garage organized may seem impossible, but not with these tips. We found the best garage storage ideas to keep ...

One of the latest advances in renewable energy is called a Battery Energy Storage System, known by the acronym BESS. There are residential versions like the Telsa Powerwall, industrial sized batteries ...

According to Anne Robertson, the bladder is not considered a particularly glamorous organ, despite hosting many of the same physiological elements and processes as the heart. Luckily for the fields of ...

LAS VEGAS--(BUSINESS WIRE)--PPG (NYSE: PPG) today announced that it achieved a GUINNESS WORLD RECORDS™ title for the largest simultaneous paint stirring challenge during a customer event at the 2025 ...

As hot rods’ paint jobs go, especially when it comes to deep color and shine, PPG finishing products have been involved with award-winning rides for decades. The 2017 Ridler Award–winning stunner that ...

Please provide your email address to receive an email when new articles are posted on . Most patients with non-muscle-invasive bladder cancer who received TAR-200 with gemcitabine achieved complete ...

Less than two months after receiving priority review status for an NDA, Johnson & Johnson won U.S. FDA approval of Inlexzo, its intravesical gemcitabine-releasing system previously known as TAR-200, ...

The FDA has approved a gemcitabine intravesical system for Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS), either with or without ...

First and only drug releasing system to provide extended local delivery of a cancer medication into the bladder, with 82 percent of patients achieving complete response without the need for ...

Imagine this: all your family photos, critical work documents, and favorite media files stored securely in one place, accessible anytime, anywhere, without relying on third-party services. Sounds ...

A new drug-releasing system, TAR-200, eliminated tumors in 82% of patients in a phase 2 clinical trial for individuals with high-risk non-muscle-invasive bladder cancer whose cancer had previously ...